title: Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population.
abstract: OBJECTIVE
  To explore the potential association between single-nucleotide polymorphisms (SNPs) and haplotypes of the CHRNA5-CHRNA3-CHRNB4 gene cluster and the non-small cell lung cancer (NSCLC) susceptibility in never-smoking Chinese.
  
  
  METHODS
  A case-control study was conducted with 200 NSCLC patients and 200 healthy controls, matched on age and sex. Five SNPs distributed in CHRNA5-CHRNA3-CHRNB4 gene cluster were selected for genotyping. The association between genotype and lung cancer risk was evaluated by computing the odds ratio (OR) and 95% confidence interval (CI) from multivariate unconditional logistic regression analyses with adjustment for gender and age.
  
  
  RESULTS
  For CHRNA3 rs578776 status, data were available in 199 NSCLC patients and 199 controls. The G/G homozygote in CHRNB4 rs7178270 had a reduced risk of developing NSCLC (OR = 0.553; 95% CI = 0.309-0.989; P = .0437), especially squamous cell carcinoma (SQC) (OR = 0.344; 95% CI = 0.161-0.732; P = .0043), compared with those who carry at least one C allele (C/C and C/G). The polymorphisms of rs578776, rs938682, rs17486278, and rs11637635 were not significantly different between controls and cases or between controls and histologic subgroups, adenocarcinoma and SQC, respectively.
  
  
  CONCLUSIONS
  In our study, we found that the SNP of CHRNB4 rs7178270 is significantly associated with reduced risk of NSCLC, especially with reduced risk of SQC in never-smoking Chinese population.
authors: Zhejiang Chinese Medicine University, Hangzhou, China.
authors: Zhijun
authors: Z
authors: Li
authors: Suzhen
authors: S
authors: Bao
authors: Xiaohong
authors: X
authors: Xu
authors: Yejiang
authors: Y
authors: Bao
authors: Yongjun
authors: Y
authors: Zhang
references: Cancer Res. 2008 Nov 15;68(22):9137-40
references: 19010884
references: Nature. 2008 Apr 3;452(7187):633-7
references: 18385738
references: Cancer Res. 2009 Jun 15;69(12):5065-72
references: 19491260
references: Lung Cancer. 2008 Sep;61(3):309-16
references: 18336951
references: Gene. 2012 Apr 10;497(1):93-7
references: 22310392
references: Clin Lung Cancer. 2006 May;7(6):389-94
references: 16800964
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Nature. 2008 Apr 3;452(7187):638-642
references: 18385739
references: Cancer Res. 2009 Aug 15;69(16):6633-41
references: 19654303
references: J Thorac Oncol. 2010 May;5(5):658-66
references: 20234319
references: Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3517-25
references: 19029397
references: Am J Psychiatry. 2008 Sep;165(9):1163-71
references: 18519524
references: Rev Med Liege. 2007 Sep;62(9):548-53
references: 17966790
references: Int J Cancer. 1994 Nov 15;59(4):494-504
references: 7960219
references: Respirology. 2005 Sep;10(4):408-17
references: 16135162
references: J Clin Invest. 2003 Jan;111(1):31-3
references: 12511585
references: Lancet. 2005 Nov 19;366(9499):1784-93
references: 16298215
references: Carcinogenesis. 2009 Jan;30(1):65-70
references: 19005185
references: Hum Mol Genet. 2007 Jan 1;16(1):36-49
references: 17135278
references: J Natl Cancer Inst. 2008 Sep 17;100(18):1326-30
references: 18780872
references: Nat Genet. 2008 May;40(5):616-22
references: 18385676
references: N Engl J Med. 2005 Jul 14;353(2):133-44
references: 16014883
references: Hum Mol Genet. 2010 Sep 15;19(18):3652-61
references: 20587604